Roche highlights data that demonstrate a range of new approaches to target breast, skin and lung cancers
19 September 2011 | By Roche
Data show greater understanding of disease pathways and personalising treatments...
List view / Grid view
News
Merck’s ISENTRESS® (raltegravir) in combination therapy demonstrated efficacy and tolerability in an observational trial
19 September 2011 | By
Results from the REALMRK clinical study...
Tecan’s Cavro® Omni Robot opens up new applications for modern circular dichroism
15 September 2011 | By kdm communications limited
Cavro® Omni Robot incorporated into Applied Photophysics’ new protein discovery solution...
GSK and McLaren Group announce innovative strategic partnership
15 September 2011 | By GSK
GlaxoSmithKline announced that it has formed a long term strategic partnership with McLaren Group...
Pfizer extends subsequent offering period of tender offer to acquire Icagen, Inc.
13 September 2011 | By Pfizer
Eclipse, extended the expiration date of the subsequent offering period of its tender offer...
Novartis increases growth potential through integration of Alcon
13 September 2011 | By Novartis
Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability...
GSK commits $1 million in cervical cancer vaccine
13 September 2011 | By GSK
A new cooperative effort aimed at reducing deaths from women's cancers...
People with type 2 diabetes experience greater improvements in glycaemic control when using Victoza®
13 September 2011 | By Novo Nordisk
Patient satisfaction when switching from sitagliptin to Victoza®...
GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease
12 September 2011 | By GSK
The first patient has commenced dosing in a Phase III global registration study...
Analyses find type 2 diabetes patients treated with BYDUREON™ experienced reduction in cardiovascular risk factors
12 September 2011 | By Eli Lilly and Company
Results presented at EASD 2011...
Lyxumia® (lixisenatide) one-step regimen as effective as two-step regimen in improving glycemic control in type 2 diabetes
12 September 2011 | By Sanofi
New phase III data from GetGoal-F1 study...
IDBS Celebrates Queen’s Award for International Trade
IDBS, a global provider of innovative data management, analytics and modeling solutions, was awarded the Queen's Award for Enterprise in the International Trade category on Tuesday September 6.
B&W Tek announces enhanced high resolution Raman spectrometer
9 September 2011 | By B&W Tek, Inc.
B&W Tek, Inc., has recently enhanced the industry leading i-Raman® high resolution TE cooled Raman spectrometer...
Lapatinib clinical trial update
9 September 2011 | By GSK
A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...
Abbott initiates international ABSORB BTK clinical trial for treatment of below-the-knee critical limb ischemia
8 September 2011 | By Abbott
Abbott announced the initiation of ABSORB BTK...
